{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:10:05Z","timestamp":1758057005782,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006586","name":"Centre Hospitalier Universitaire de Nice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.encep.2020.09.010","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T15:37:04Z","timestamp":1612453024000},"page":"227-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["La pharmacor\u00e9sistance aux psychotropes chez l\u2019enfant et l\u2019adolescent\u00a0: recherche d\u2019anomalies pharmacog\u00e9n\u00e9tiques du cytochrome P450 2D6"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-9096","authenticated-orcid":false,"given":"A.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-L.","family":"Menard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cruzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Askenazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Verstuyft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-6981","authenticated-orcid":false,"given":"S.","family":"Th\u00fcmmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2020.09.010_bib0215","first-page":"75","article-title":"M\u00e9dicaments psychotropes\u00a0: consommations et pratiques de prescription en France m\u00e9tropilitaine. I. Donn\u00e9es nationales, 2000","volume":"34","author":"Lecadet","year":"2003","journal-title":"Rev Med Assoc Mal"},{"key":"10.1016\/j.encep.2020.09.010_bib0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/cap.2005.15.10","article-title":"Pharmacoepidemiology and pediatric psychopharmacology research","volume":"15","author":"Vitiello","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2020.09.010_bib0225","doi-asserted-by":"crossref","first-page":"e011020","DOI":"10.1136\/bmjopen-2015-011020","article-title":"Incidence of adverse events in antipsychotic-na\u00efve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE)","volume":"6","author":"Menard","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.encep.2020.09.010_bib0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.arcped.2014.10.011","article-title":"Am\u00e9liorer la surveillance de la tol\u00e9rance p\u00e9diatrique des antipsychotiques en France","volume":"22","author":"Menard","year":"2015","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.encep.2020.09.010_bib0235","first-page":"535","article-title":"Les cytochromes P450\u00a0: m\u00e9tabolisme des x\u00e9nobiotiques, r\u00e9gulation et r\u00f4le en clinique","volume":"64","author":"Gu\u00e9guen","year":"2006","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.encep.2020.09.010_bib0240","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003088-199835050-00003","article-title":"Inhibition and induction of cytochrome P450\u00a0and the clinical implications","volume":"35","author":"Lin","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.encep.2020.09.010_bib0245","first-page":"421","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.encep.2020.09.010_bib0250","first-page":"17","article-title":"The influence of cytochrome P450\u00a0pharmacogenetics on disposition of common antidepressant and antipsychotic medications","volume":"27","author":"Van der Weide","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.encep.2020.09.010_bib0255","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.therap.2016.09.012","article-title":"Pharmacog\u00e9n\u00e9tique des m\u00e9dicaments antid\u00e9presseurs\u00a0: \u00e9tat des connaissances et des pratiques \u2013 recommandations du R\u00e9seau national de pharmacog\u00e9n\u00e9tique (RNPGx)","volume":"72","author":"Quaranta","year":"2017","journal-title":"Therapie"},{"key":"10.1016\/j.encep.2020.09.010_bib0260","first-page":"9","article-title":"Pharmacoresistant severe mental health disorders in children and adolescents: functional abnormalities of cytochrome P450 2D6","author":"Th\u00fcmmler","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.encep.2020.09.010_bib0265","unstructured":"Centre d'informations th\u00e9rapeutique et de pharmacovigilance de Gen\u00e8ve. Table \u2018Interactions m\u00e9dicamenteuses, cytochromes P450 et P-glycoprot\u00e9ine (Pgp)\u2019. 2020. [cit\u00e9 01\/06\/2020] Available from : URL :https:\/\/www.hug.ch\/sites\/interhug\/files\/structures\/pharmacologie_et_toxicologie_cliniques\/images\/carte_des_cytochromes_2020.pdf."},{"key":"10.1016\/j.encep.2020.09.010_bib0270","unstructured":"Vidal. Le Dictionnaire. Edition 2018. Paris : Ed. Vidal ; 2018."},{"year":"2008","series-title":"Le bon usage des antid\u00e9presseurs chez l\u2019enfant et l\u2019adolescent. Mise au point","author":"AFSSAPS.","key":"10.1016\/j.encep.2020.09.010_bib0275"},{"issue":"Suppl4","key":"10.1016\/j.encep.2020.09.010_bib0280","doi-asserted-by":"crossref","first-page":"H15","DOI":"10.1016\/S0013-7006(11)70028-8","article-title":"Les antipsychotiques atypiques chez l\u2019adolescent\u00a0: quels enjeux pour l\u2019avenir\u00a0?","volume":"37","author":"Cohen","year":"2011","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2020.09.010_bib0285","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurenf.2018.12.003","article-title":"Pharmacor\u00e9sistance aux psychotropes et anomalies pharmacog\u00e9n\u00e9tiques du cytochrome P450 2D6\u00a0: vers une m\u00e9decine personnalis\u00e9e en p\u00e9dopsychiatrie, pr\u00e9sentation d\u2019un protocole de recherche","volume":"67","author":"David","year":"2019","journal-title":"Neuropsychiatr Enfance Adolesc"},{"key":"10.1016\/j.encep.2020.09.010_bib0290","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.2013.2","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2D6\u00a0and CYP2C19\u00a0genotypes and dosing of tricyclic antidepressants","volume":"93","author":"Hicks","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.encep.2020.09.010_bib0295","first-page":"499","article-title":"La pharmacog\u00e9n\u00e9tique ou la promesse d\u2019une m\u00e9decine personnalis\u00e9e\u00a0: variations du m\u00e9tabolisme et du transport des m\u00e9dicaments","volume":"62","author":"Allorge","year":"2004","journal-title":"Ann Biol Clin"},{"key":"10.1016\/j.encep.2020.09.010_bib0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/cap.2000.10.27","article-title":"Fluoxetine-related death in a child with cytochrome P-450 2D6\u00a0genetic deficiency","volume":"10","author":"Sallee","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2020.09.010_bib0305","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00228-003-0701-4","article-title":"Increased incidence of CYP2D6\u00a0gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of non-response. A pilot study","volume":"59","author":"Kawanishi","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.encep.2020.09.010_bib0310","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/dmcn.12470","article-title":"CYP2D6\u00a0genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study","volume":"56","author":"Youngster","year":"2014","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.encep.2020.09.010_bib0315","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00431-013-2208-z","article-title":"Neuroleptic malignant syndrome in an adolescent with CYP2D6\u00a0deficiency","volume":"173","author":"Butwicka","year":"2014","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.encep.2020.09.010_bib0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/cap.2008.0103","article-title":"Drug-metabolising enzyme genotypes and aggressive behaviour treatment response in hospitalised pediatric psychiatric patients","volume":"19","author":"Prows","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2020.09.010_bib0325","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/FPC.0b013e3283659a94","article-title":"CYP2D6\u00a0poor metaboliser status might be associated with better response to risperidone treatment","volume":"23","author":"Almoguera","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.encep.2020.09.010_bib0330","first-page":"877","article-title":"Molecular study of weight gain related to atypical antipsychotics: clinical implications of the CYP2D6\u00a0genotype","volume":"55","author":"Nussbaum","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.encep.2020.09.010_bib0335","first-page":"11","article-title":"The response to atypical antipsychotic drugs in correlation with the CYP2D6\u00a0genotype: clinical implications and perspectives","volume":"62","author":"Nussbaum","year":"2014","journal-title":"Farmacia"},{"key":"10.1016\/j.encep.2020.09.010_bib0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2004.01.004","article-title":"Allele and genotype frequencies of CYP2C9, CYP2C19\u00a0and CYP2D6\u00a0in an Italian population","volume":"50","author":"Scordo","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.encep.2020.09.010_bib0345","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3565(25)20152-5","article-title":"Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6\u00a0alleles","volume":"278","author":"Aklillu","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.encep.2020.09.010_bib0350","unstructured":"CNPM. Les sources de variabilit\u00e9 de la r\u00e9ponse au m\u00e9dicament - Variabilit\u00e9s pharmacocin\u00e9tiques. 2019. Avaliable from : URL :https:\/\/pharmacomedicale.org\/pharmacologie\/les-sources-de-variabilite-de-la-reponse-au-medicament\/45-variabilites-pharmacocinetiques"},{"key":"10.1016\/j.encep.2020.09.010_bib0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(03)00249-X","article-title":"The development of drug metabolising enzymes and their influence on the susceptibility to adverse drug reactions in children","volume":"192","author":"Johnson","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.encep.2020.09.010_bib0360","unstructured":"ANSM. Interactions m\u00e9dicamenteuses et cytochromes. 2019. [cit\u00e9 7 janv 2019]. Disponible sur : URL : https:\/\/www.ansm.sante.fr\/Dossiers\/Interactions-medicamenteuses\/Interactions-medicamenteuses-et-cytochromes\/."},{"year":"1988","series-title":"Biotransformation des m\u00e9dicaments\u00a0: voies biomol\u00e9culaires et pharmacologie clinique","author":"Bechtel","key":"10.1016\/j.encep.2020.09.010_bib0365"},{"key":"10.1016\/j.encep.2020.09.010_bib0370","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3109\/07853890.2011.583675","article-title":"Therapeutic options in treatment-resistant depression","volume":"43","author":"Vieta","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.encep.2020.09.010_bib0375","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.encep.2014.11.002","article-title":"French Society for biological psychiatry and neuropsychopharmacology task force. Formal consensus for the treatment of bipolar disorder: an update (2014)","volume":"41","author":"Samalin","year":"2015","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2020.09.010_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psychres.2012.02.013","article-title":"Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation","volume":"197","author":"Suzuki","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.encep.2020.09.010_bib0385","unstructured":"EMA. Guideline on clinical investigation of medicinal products in the treatment of depression [Internet]. 2012. [cit\u00e9 31 ao\u00fbt 2018]. Available from : URL : http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2013\/05\/WC500143770.pd."},{"key":"10.1016\/j.encep.2020.09.010_bib0390","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00004583-200209000-00003","article-title":"Sertraline pharmacokinetics and dynamics in adolescents","volume":"41","author":"Axelson","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"year":"2007","series-title":"Les prescriptions m\u00e9dicamenteuses en psychiatrie de l\u2019enfant et de l\u2019adolescent","author":"Bailly","key":"10.1016\/j.encep.2020.09.010_bib0395"},{"key":"10.1016\/j.encep.2020.09.010_bib0400","unstructured":"ICH. Addendum to ICH E11: clinical investigation of medicinal products in the pediatric population. E11 (R1). 2017. [cit\u00e9 4 septembre 2020]. Available from : URL : https:\/\/database.ich.org\/sites\/default\/files\/E11_R1_Addendum.pdf"},{"key":"10.1016\/j.encep.2020.09.010_bib0405","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/cap.2005.15.5","article-title":"Recent child pharmacoepidemiological findings","volume":"15","author":"Zito","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2020.09.010_bib0410","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(06)69255-6","article-title":"Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother","volume":"368","author":"Koren","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2020.09.010_bib0415","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.neurenf.2019.10.002","article-title":"P\u00e9dopsychiatrie et pharmacog\u00e9n\u00e9tique\u00a0: pharmacor\u00e9sistance aux psychotropes et duplication du cytochrome P450 2D6, \u00e0 propos de trois cas cliniques","volume":"67","author":"David","year":"2019","journal-title":"Neuropsychiatr Enfance Adolesc"},{"key":"10.1016\/j.encep.2020.09.010_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.encep.2020.02.004","article-title":"Pharmacor\u00e9sistance et effets secondaires des antipsychotiques associ\u00e9s \u00e0 un ph\u00e9notype m\u00e9taboliseur lent pour le cytochrome P450 2D6\u00a0dans un contexte de schizophr\u00e9nie tr\u00e8s pr\u00e9coce\u00a0: \u00e0 propos d\u2019un cas clinique","author":"David","year":"2020","journal-title":"Enc\u00e9phale"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:39:36Z","timestamp":1757957976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700621000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0013700621000221"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2020.09.010","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La pharmacor\u00e9sistance aux psychotropes chez l\u2019enfant et l\u2019adolescent\u00a0: recherche d\u2019anomalies pharmacog\u00e9n\u00e9tiques du cytochrome P450 2D6","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2020.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}